Although adiponectin has been utilized for prognostic purposes in sepsis, its association with obesity, insulin resistance, diabetes, and inflammatory diseases implies that the clinical trajectories and outcomes of sepsis patients with these underlying conditions may vary significantly. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.